PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis • Value chain analysis PART 04: MARKET SIZING • Market definition • Market sizing 2019 • Market size and forecast 2019-2024 • Market Outlook PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY TYPE • Market segmentation by type • Comparison by type • Therapeutic - Market size and forecast 2019-2024 • Non-therapeutic - Market size and forecast 2019-2024 • Market opportunity by type PART 07: CUSTOMER LANDSCAPE PART 08: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • North America - Market size and forecast 2019-2024 • Europe - Market size and forecast 2019-2024 • Asia - Market size and forecast 2019-2024 • ROW - Market size and forecast 2019-2024 • Key leading countries • Market opportunity PART 09: DECISION FRAMEWORK PART 10: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 11: MARKET TRENDS • Technological advances in sterilization equipment • Rising awareness about infectious diseases • Growing risk of spreading infections via blood transfusions PART 12: VENDOR LANDSCAPE • Overview • Landscape disruption • Competitive scenario PART 13: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • 3M Co. • Astellas Pharma Inc. • Cantel Medical Corp. • Ecolab Inc. • Getinge AB • GlaxoSmithKline Plc • Merck & Co. Inc. • Mylan NV • Pfizer Inc. • Sanofi PART 14: APPENDIX • Research methodology • List of abbreviations • Definition of market positioning of vendors PART 15: EXPLORE TECHNAVIO   Exhibit 01: Vendors: Key offerings Exhibit 02: Global healthcare market Exhibit 03: Segments of global healthcare market Exhibit 04: Market characteristics Exhibit 05: Market segments Exhibit 06: Market definition - Inclusions and exclusions checklist Exhibit 07: Market size 2019 Exhibit 08: Global market: Size and forecast 2019-2024 ($ billions) Exhibit 09: Global market: Year-over-year growth 2020-2024 (%) Exhibit 10: Five forces analysis 2019 Exhibit 11: Five forces analysis 2024 Exhibit 12: Bargaining power of buyers Exhibit 13: Bargaining power of suppliers Exhibit 14: Threat of new entrants Exhibit 15: Threat of substitutes Exhibit 16: Threat of rivalry Exhibit 17: Market condition - Five forces 2019 Exhibit 18: Type - Market share 2019-2024 (%) Exhibit 19: Comparison by type Exhibit 20: Therapeutic - Market size and forecast 2019-2024 ($ billions) Exhibit 21: Therapeutic - Year-over-year growth 2020-2024 (%) Exhibit 22: Non-therapeutic - Market size and forecast 2019-2024 ($ billions) Exhibit 23: Non-therapeutic - Year-over-year growth 2020-2024 (%) Exhibit 24: Market opportunity by type Exhibit 25: Customer landscape Exhibit 26: Market share by geography 2019-2024 (%) Exhibit 27: Geographic comparison Exhibit 28: North America - Market size and forecast 2019-2024 ($ billions) Exhibit 29: North America - Year-over-year growth 2020-2024 (%) Exhibit 30: Top 3 countries in North America Exhibit 31: Europe - Market size and forecast 2019-2024 ($ billions) Exhibit 32: Europe - Year-over-year growth 2020-2024 (%) Exhibit 33: Top 3 countries in Europe Exhibit 34: Asia - Market size and forecast 2019-2024 ($ billions) Exhibit 35: Asia - Year-over-year growth 2020-2024 (%) Exhibit 36: Top 3 countries in Asia Exhibit 37: ROW - Market size and forecast 2019-2024 ($ billions) Exhibit 38: ROW - Year-over-year growth 2020-2024 (%) Exhibit 39: Top 3 countries in ROW Exhibit 40: Key leading countries Exhibit 41: Market opportunity Exhibit 42: Ambulatory surgery procedures and visits to hospitals and ambulatory surgery centers in the US, 2010 Exhibit 43: Impact of drivers and challenges Exhibit 44: Vendor landscape Exhibit 45: Landscape disruption Exhibit 46: Vendors covered Exhibit 47: Vendor classification Exhibit 48: Market positioning of vendors Exhibit 49: 3M Co. - Vendor overview Exhibit 50: 3M Co. - Business segments Exhibit 51: 3M Co. - Organizational developments Exhibit 52: 3M Co. - Geographic focus Exhibit 53: 3M Co. - Segment focus Exhibit 54: 3M Co. - Key offerings Exhibit 55: Astellas Pharma Inc. - Vendor overview Exhibit 56: Astellas Pharma Inc. - Business segments Exhibit 57: Astellas Pharma Inc. - Organizational developments Exhibit 58: Astellas Pharma Inc. - Geographic focus Exhibit 59: Astellas Pharma Inc. - Key offerings Exhibit 60: Cantel Medical Corp. - Vendor overview Exhibit 61: Cantel Medical Corp. - Business segments Exhibit 62: Cantel Medical Corp. - Organizational developments Exhibit 63: Cantel Medical Corp. - Geographic focus Exhibit 64: Cantel Medical Corp. - Segment focus Exhibit 65: Cantel Medical Corp. - Key offerings Exhibit 66: Ecolab Inc. - Vendor overview Exhibit 67: Ecolab Inc. - Business segments Exhibit 68: Ecolab Inc. - Organizational developments Exhibit 69: Ecolab Inc. - Geographic focus Exhibit 70: Ecolab Inc. - Segment focus Exhibit 71: Ecolab Inc. - Key offerings Exhibit 72: Getinge AB - Vendor overview Exhibit 73: Getinge AB - Business segments Exhibit 74: Getinge AB - Organizational developments Exhibit 75: Getinge AB - Geographic focus Exhibit 76: Getinge AB - Segment focus Exhibit 77: Getinge AB - Key offerings Exhibit 78: GlaxoSmithKline Plc - Vendor overview Exhibit 79: GlaxoSmithKline Plc - Business segments Exhibit 80: GlaxoSmithKline Plc - Organizational developments Exhibit 81: GlaxoSmithKline Plc - Geographic focus Exhibit 82: GlaxoSmithKline Plc - Segment focus Exhibit 83: GlaxoSmithKline Plc - Key offerings Exhibit 84: Merck & Co. Inc. - Vendor overview Exhibit 85: Merck & Co. Inc. - Business segments Exhibit 86: Merck & Co. Inc. - Organizational developments Exhibit 87: Merck & Co. Inc. - Geographic focus Exhibit 88: Merck & Co. Inc. - Segment focus Exhibit 89: Merck & Co. Inc. - Key offerings Exhibit 90: Mylan NV - Vendor overview Exhibit 91: Mylan NV - Product segments Exhibit 92: Mylan NV - Organizational developments Exhibit 93: Mylan NV - Geographic focus Exhibit 94: Mylan NV - Segment focus Exhibit 95: Mylan NV - Key offerings Exhibit 96: Pfizer Inc. - Vendor overview Exhibit 97: Pfizer Inc. - Business segments Exhibit 98: Pfizer Inc. - Organizational developments Exhibit 99: Pfizer Inc. - Geographic focus Exhibit 100: Pfizer Inc. - Segment focus Exhibit 101: Pfizer Inc. - Key offerings Exhibit 102: Sanofi - Vendor overview Exhibit 103: Sanofi - Business segments Exhibit 104: Sanofi - Organizational developments Exhibit 105: Sanofi - Geographic focus Exhibit 106: Sanofi - Segment focus Exhibit 107: Sanofi - Key offerings Exhibit 108: Validation techniques employed for market sizing Exhibit 109: Definition of market positioning of vendors

3M Co., Astellas Pharma Inc., Cantel Medical Corp., Ecolab Inc., Getinge AB, GlaxoSmithKline Plc, Merck & Co. Inc., Mylan NV, Pfizer Inc., and Sanofi.